Food allergies occur when the immune system (the body’s defence against infection) mistakenly treats proteins found in food as a threat.
Symptoms range from skin redness, hives and swelling, in the most severe cases – vomiting, diarrhoea, difficulty breathing and anaphylaxis which can lead to death.
Almost any food can cause an adverse reaction, such as wheat, gluten, egg, milk and tree nuts.
Allergy Therapeutics (LON:AGY) is an international commercial biotechnology group focused on the treatment and diagnosis of allergic disorders, including immunotherapy vaccines that have the potential to cure disease. The Group sells proprietary and third-party products from its subsidiaries in nine major European countries and via distribution agreements in an additional fourteen countries. Its broad pipeline of products in clinical development include vaccines for grass, tree and house dust mite, and peanut allergy vaccine in pre-clinical development. Adjuvant systems to boost performance of vaccines outside allergy are also in development.